Literature DB >> 2885390

Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.

D Kerjaschki, A Miettinen, M G Farquhar.   

Abstract

The nephritogenic antigen of Heymann's nephritis (HN), gp330, was previously demonstrated (4-9) to be a resident glycoprotein of coated pits in the glomerular and proximal tubule epithelium of rats, and anti-gp330 IgG given intravenously was found to form IDs in glomeruli (passive HN). The purpose of this study was to investigate the detailed events that occur in the formation of IDs in passive HN. HN was induced by the injection of either 125I-labeled or unlabeled anti-gp330 IgG. At various times after injection (15 min to 8 d) the kidneys of some of the injected rats were fixed by perfusion, and the distribution of the rabbit IgG was determined by immunofluorescence and by immunoelectron microscopy. Glomeruli were isolated from the kidneys of injected rats and used for isolation of GBM fractions or for elution of the bound IgG. At 15 min to 1 h after injection, the rabbit IgG was localized by immunocytochemistry exclusively in coated pits along the podocyte plasmalemma facing the GBM. By 1-8 d, anti-gp330 IgG was detected in larger electron-dense IDs often located under the slit diaphragms. Serial sectioning revealed that each of the IDs maintained contact with a coated pit at some level. When GBMs isolated from rats given radiolabeled anti-gp330 IgG were examined by electron microscopy, the IDs were found to remain attached to the GBMs as early as 15 min after injection and coisolated with them at all time points. By double-immunolabeling of the isolated GBMs with two sizes of gold particles, both the antigen (gp330) and the anti-gp330 IgG could be demonstrated in IDs at all time points. When the amount of radiolabeled anti-gp330 bound to GBM fractions was compared with that of isolated glomeruli, it was found that 20% of the radiolabel remained bound to the purified GBMs at 15 min after injection, and 90% at 3 d. The bound IgG was released only by treatments that disrupt antibody-antigen complexes (high and low pH), but not by the other treatments we tried (detergent, high salt, heparinase, or collagenase digestion). When the IgG bound to glomeruli was eluted with acid citrate buffer 3 d after injection, it was found to specifically immunoprecipitate only gp330 from detergent-solubilized 125I-labeled kidney microvillar vesicles. By isoelectric focusing the eluate was found to be enriched in IgGs with acidic isoelectric points.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885390      PMCID: PMC2188651          DOI: 10.1084/jem.166.1.109

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

Review 1.  Complement and the direct mediation of immune glomerular injury: a new perspective.

Authors:  W G Couser; P J Baker; S Adler
Journal:  Kidney Int       Date:  1985-12       Impact factor: 10.612

2.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

3.  Polyvalent antigen-antibody interactions are required for the formation of electron-dense immune deposits in passive Heymann's nephritis.

Authors:  L Allegri; E Brianti; F Chatelet; G C Manara; P Ronco; P Verroust
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

4.  Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium.

Authors:  M W Seiler; H G Rennke; M A Venkatachalam; R S Cotran
Journal:  Lab Invest       Date:  1977-01       Impact factor: 5.662

5.  Production and characterization of monoclonal antibodies against rat brush border antigens of the proximal convoluted tubule.

Authors:  P Ronco; C Melcion; M Geniteau; E Ronco; L Reininger; M Galceran; P Verroust
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

6.  Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.

Authors:  A K Bhan; E E Schneeberger; L G Baird; A B Collins; K Kamata; D Bradford; M E Erikson; R T McCluskey
Journal:  Lab Invest       Date:  1985-10       Impact factor: 5.662

7.  An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis.

Authors:  P Ronco; T J Neale; C B Wilson; M Galceran; P Verroust
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.

Authors:  G Camussi; J R Brentjens; B Noble; D Kerjaschki; F Malavasi; O A Roholt; M G Farquhar; G Andres
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Characterization of antigens and antibody specificities involved in Heymann nephritis.

Authors:  K Kamata; L G Baird; M E Erikson; A B Collins; R T McCluskey
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier.

Authors:  J P Caulfield; M G Farquhar
Journal:  J Cell Biol       Date:  1974-12       Impact factor: 10.539

View more
  51 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1.

Authors:  Shenaz Khan; Sujata Lakhe-Reddy; Joseph H McCarty; Christine M Sorenson; Nader Sheibani; Louis F Reichardt; Jane H Kim; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  The solution structure of the N-terminal domain of alpha2-macroglobulin receptor-associated protein.

Authors:  P R Nielsen; L Ellgaard; M Etzerodt; H C Thogersen; F M Poulsen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IgGs by immunoelectron microscopy.

Authors:  G Dekan; A Miettinen; E Schnabel; M G Farquhar
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

Review 5.  Molecular development of immune deposits and proteinuria in Heymann nephritis.

Authors:  D Kerjaschki
Journal:  Clin Investig       Date:  1993-10

6.  Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

Authors:  B V Zlokovic; C L Martel; E Matsubara; J G McComb; G Zheng; R T McCluskey; B Frangione; J Ghiso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 7.  Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.

Authors:  M G Farquhar
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

8.  A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.

Authors:  Y Tsukada; K Ono; A Maezawa; S Yano; T Naruse
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.

Authors:  I Warshawsky; G Bu; A Mast; J E Saffitz; G J Broze; A L Schwartz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex.

Authors:  R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.